When did OCUPHIRE PHARMA INC (OCUP) report earnings last quarter?
OCUPHIRE PHARMA INC (OCUP) last reported earnings on 8/13/2024.
NASDAQ:OCUP • US67577R1023
Past quarterly earnings results for OCUPHIRE PHARMA INC (OCUP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -0.30 | -0.26 | -15.34% | -25.00% | 1.112M | 2.509M | -55.68% | -69.73% |
| Q1 2024 | -0.29 | -0.14 | -112.17% | -3.57% | 1.711M | 4.337M | -60.55% | -2.17% |
| Q4 2023 | -0.21 | -0.05 | -292.16% | -113.29% | 1.691M | 5.456M | -69.01% | -95.76% |
| Q3 2023 | 0.25 | -0.23 | 210.40% | 213.64% | 11.935M | 3.086M | 286.75% | - |
| Q2 2023 | -0.24 | -0.23 | -4.11% | 4.00% | 3.674M | 2.474M | 48.50% | - |
| Q1 2023 | -0.28 | -0.16 | -78.25% | 20.00% | 1.749M | 3.01M | -41.89% | - |
| Q4 2022 | 1.58 | 0.99 | 60.11% | 551.43% | 39.85M | 30.034M | 32.68% | - |
| Q3 2022 | -0.22 | -0.29 | 25.19% | 12.00% | - | -100.00% | ||
| Q2 2022 | -0.25 | -0.34 | 26.18% | 51.92% | - | -100.00% | ||
| Q1 2022 | -0.35 | -0.36 | 1.96% | 25.53% | - | - | ||
| Q4 2021 | -0.35 | -0.29 | -19.70% | 93.24% | - | 100.00% | ||
| Q3 2021 | -0.25 | -0.37 | 31.54% | 24.24% | 490K | - | - | |
| Q2 2021 | -0.52 | -0.37 | -40.31% | 16.13% | 100K | - | - | |
| Q1 2021 | -0.47 | -0.73 | 35.33% | -213.33% | - | -100.00% | ||
| Q4 2020 | -5.18 | -0.43 | -1,109.15% | - | -1.15M | - | - | |
| Q3 2020 | -0.33 | - | - | - | - | |||
| Q2 2020 | -0.62 | - | - | - | - | |||
| Q1 2020 | -0.15 | - | - | 1.15M | - | - |
Notes
OCUPHIRE PHARMA INC (OCUP) last reported earnings on 8/13/2024.
OCUPHIRE PHARMA INC (OCUP) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, OCUPHIRE PHARMA INC (OCUP) has beaten EPS estimates in 1 out of 4 releases.